Sara Moiz Tyebally
Research Subjects
Sara Moiz Tyebally has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ainsley Ryan Yan Bin Lee
Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
1 shared publication - Chen Ee Low
Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
1 shared publication - Chia-Te Liao
Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan
1 shared publication - Chieh Yang Koo
Department of Cardiology, National University Heart Centre Singapore, Singapore
1 shared publication - Ching-Hui Sia
Department of Cardiology, National University Heart Centre Singapore, Singapore
1 shared publication - Chun En Yau
Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
1 shared publication
Latest Publications
- Open Access
- 20 December 2022
- Published by MDPI AG in Preprints.org
Natural Progression of Left Ventricular Function Following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis
Background: Anthracyclines form the backbone of many systemic chemotherapy regimens but dose-limiting cardiotoxicity can also lead to reduction in cardiac function and an increased risk of heart failure. Methods: This review was conducted in accordance with PRISMA guidelines and registered on PROSPERO (CRD42022373496). Results: 26 studies met the eligibility criteria including a total of 910 patients. Overall reduction in pooled mean left ventricular ejection fraction (LVEF) post‐anthracyclines in the placebo arms of included randomised-controlled trials was 4.6% (95% CI, 2.7 to 6.6). The trend in LVEF showed a progressive decline until approximately 180 days after which there was no significant change. Those receiving a cumulative anthracycline dose 300 mg/m2 experienced a more profound reduction. The risk of a 10% absolute decline in LVEF from baseline or decline to an LVEF below 50%, the overall pooled risk was 16% (95% CI: 11 to 21; I2 = 77%). Sensitivity analyses by baseline LVEF and trastuzumab treatment status did not yield significant differences. Conclusion: While the mean LVEF decline in patients without cardioprotective therapy was clinically small, a vulnerable subset experienced significant impairment. Further research to best identify those who benefit most from cardioprotective therapies when receiving anthracyclines are required.
- 20 December 2022
- Published by MDPI AG in Preprints.org
Open AccessNatural Progression of Left Ventricular Function Following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis
Background: Anthracyclines form the backbone of many systemic chemotherapy regimens but dose-limiting cardiotoxicity can also lead to reduction in cardiac function and an increased risk of heart failure. Methods: This review was conducted in accordance with PRISMA guidelines and registered on PROSPERO (CRD42022373496). Results: 26 studies met the eligibility criteria including a total of 910 patients. Overall reduction in pooled mean left ventricular ejection fraction (LVEF) post‐anthracyclines in the placebo arms of included randomised-controlled trials was 4.6% (95% CI, 2.7 to 6.6). The trend in LVEF showed a progressive decline until approximately 180 days after which there was no significant change. Those receiving a cumulative anthracycline dose 300 mg/m2 experienced a more profound reduction. The risk of a 10% absolute decline in LVEF from baseline or decline to an LVEF below 50%, the overall pooled risk was 16% (95% CI: 11 to 21; I2 = 77%). Sensitivity analyses by baseline LVEF and trastuzumab treatment status did not yield significant differences. Conclusion: While the mean LVEF decline in patients without cardioprotective therapy was clinically small, a vulnerable subset experienced significant impairment. Further research to best identify those who benefit most from cardioprotective therapies when receiving anthracyclines are required.